Quarterly Transactions Made in Design Therapeutics, Inc. (DSGN)
This table provides information about the institutional ownership of Design Therapeutics, Inc. (DSGN). The information is specifically focused on institutions that hold shares of Design Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 895,889 | 308,572 | 1,204,461 | 525,080 | 204,338 | 729,418 | 475,043 | |
| Q4 2021 | 3,032,536 | 6,148,743 | 9,181,279 | 784,818 | 255,364 | 1,040,182 | 8,141,097 | |
| Q1 2022 | 2,537,280 | 450,382 | 2,987,662 | 653,264 | 496,252 | 1,149,516 | 1,838,146 | |
| Q2 2022 | 1,901,938 | 222,984 | 2,124,922 | 2,031,433 | 119,153 | 2,150,586 | -25,664 | |
| Q3 2022 | 4,514,269 | 475,625 | 4,989,894 | 1,302,402 | 0 | 1,302,402 | 3,687,492 | |
| Q4 2022 | 4,642,566 | 767,034 | 5,409,600 | 4,767,406 | 0 | 4,767,406 | 642,194 | |
| Q1 2023 | 2,837,779 | 1,530,697 | 4,368,476 | 4,385,381 | 0 | 4,385,381 | -16,905 | |
| Q2 2023 | 1,108,289 | 2,091,739 | 3,200,028 | 2,618,875 | 0 | 2,618,875 | 581,153 | |
| Q3 2023 | 5,171,781 | 2,775,558 | 7,947,339 | 2,605,959 | 0 | 2,605,959 | 5,341,380 | |
| Q4 2023 | 3,252,793 | 4,488,715 | 7,741,508 | 2,683,173 | 0 | 2,683,173 | 5,058,335 | |
| Q1 2024 | 1,325,578 | 1,214,081 | 2,539,659 | 2,784,685 | 0 | 2,784,685 | -245,026 | |
| Q2 2024 | 1,672,206 | 1,444,888 | 3,117,094 | 1,602,439 | 0 | 1,602,439 | 1,514,655 | |
| Q3 2024 | 2,963,845 | 148,922 | 3,112,767 | 2,241,240 | 0 | 2,241,240 | 871,527 | |